Cargando…
CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma
The chemokine ligands and their receptors play critical roles in cancer progression and patients outcomes. We found that CXCL13 was significantly upregulated in ccRCC tissues compared with normal tissues in both The Cancer Genome Atlas (TCGA) cohort and a validated cohort of 90 pairs ccRCC tissues....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349755/ https://www.ncbi.nlm.nih.gov/pubmed/30723697 http://dx.doi.org/10.3389/fonc.2018.00682 |
_version_ | 1783390308740890624 |
---|---|
author | Zheng, Zaosong Cai, Yuhong Chen, Haicheng Chen, Zhiliang Zhu, Dingjun Zhong, Qiyu Xie, Wenlian |
author_facet | Zheng, Zaosong Cai, Yuhong Chen, Haicheng Chen, Zhiliang Zhu, Dingjun Zhong, Qiyu Xie, Wenlian |
author_sort | Zheng, Zaosong |
collection | PubMed |
description | The chemokine ligands and their receptors play critical roles in cancer progression and patients outcomes. We found that CXCL13 was significantly upregulated in ccRCC tissues compared with normal tissues in both The Cancer Genome Atlas (TCGA) cohort and a validated cohort of 90 pairs ccRCC tissues. Statistical analysis showed that high CXCL13 expression related to advanced disease stage and poor prognosis in ccRCC. We also revealed that serum CXCL13 levels in ccRCC patients (n = 50) were significantly higher than in healthy controls (n = 40). Receiver operating characteristic (ROC) curve revealed that tissue and serum CXCL13 expression might be a diagnostic biomarker for ccRCC with an area under curve (AUC) of 0.809 and 0.704, respectively. CXCL13 was significantly associated with its receptor, CXCR5, in ccRCC tissues, and ccRCC patients in high CXCL13 high CXCR5 expression group have a worst prognosis. Functional and mechanistic study revealed that CXCL13 promoted the proliferation and migration of ccRCC cells by binding to CXCR5 and activated PI3K/AKT/mTOR signaling pathway. These results suggested that CXCL13/CXCR5 axis played a significant role in ccRCC and might be a therapeutic target and prognostic biomarker. |
format | Online Article Text |
id | pubmed-6349755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63497552019-02-05 CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma Zheng, Zaosong Cai, Yuhong Chen, Haicheng Chen, Zhiliang Zhu, Dingjun Zhong, Qiyu Xie, Wenlian Front Oncol Oncology The chemokine ligands and their receptors play critical roles in cancer progression and patients outcomes. We found that CXCL13 was significantly upregulated in ccRCC tissues compared with normal tissues in both The Cancer Genome Atlas (TCGA) cohort and a validated cohort of 90 pairs ccRCC tissues. Statistical analysis showed that high CXCL13 expression related to advanced disease stage and poor prognosis in ccRCC. We also revealed that serum CXCL13 levels in ccRCC patients (n = 50) were significantly higher than in healthy controls (n = 40). Receiver operating characteristic (ROC) curve revealed that tissue and serum CXCL13 expression might be a diagnostic biomarker for ccRCC with an area under curve (AUC) of 0.809 and 0.704, respectively. CXCL13 was significantly associated with its receptor, CXCR5, in ccRCC tissues, and ccRCC patients in high CXCL13 high CXCR5 expression group have a worst prognosis. Functional and mechanistic study revealed that CXCL13 promoted the proliferation and migration of ccRCC cells by binding to CXCR5 and activated PI3K/AKT/mTOR signaling pathway. These results suggested that CXCL13/CXCR5 axis played a significant role in ccRCC and might be a therapeutic target and prognostic biomarker. Frontiers Media S.A. 2019-01-22 /pmc/articles/PMC6349755/ /pubmed/30723697 http://dx.doi.org/10.3389/fonc.2018.00682 Text en Copyright © 2019 Zheng, Cai, Chen, Chen, Zhu, Zhong and Xie. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zheng, Zaosong Cai, Yuhong Chen, Haicheng Chen, Zhiliang Zhu, Dingjun Zhong, Qiyu Xie, Wenlian CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma |
title | CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma |
title_full | CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma |
title_fullStr | CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma |
title_full_unstemmed | CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma |
title_short | CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma |
title_sort | cxcl13/cxcr5 axis predicts poor prognosis and promotes progression through pi3k/akt/mtor pathway in clear cell renal cell carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349755/ https://www.ncbi.nlm.nih.gov/pubmed/30723697 http://dx.doi.org/10.3389/fonc.2018.00682 |
work_keys_str_mv | AT zhengzaosong cxcl13cxcr5axispredictspoorprognosisandpromotesprogressionthroughpi3kaktmtorpathwayinclearcellrenalcellcarcinoma AT caiyuhong cxcl13cxcr5axispredictspoorprognosisandpromotesprogressionthroughpi3kaktmtorpathwayinclearcellrenalcellcarcinoma AT chenhaicheng cxcl13cxcr5axispredictspoorprognosisandpromotesprogressionthroughpi3kaktmtorpathwayinclearcellrenalcellcarcinoma AT chenzhiliang cxcl13cxcr5axispredictspoorprognosisandpromotesprogressionthroughpi3kaktmtorpathwayinclearcellrenalcellcarcinoma AT zhudingjun cxcl13cxcr5axispredictspoorprognosisandpromotesprogressionthroughpi3kaktmtorpathwayinclearcellrenalcellcarcinoma AT zhongqiyu cxcl13cxcr5axispredictspoorprognosisandpromotesprogressionthroughpi3kaktmtorpathwayinclearcellrenalcellcarcinoma AT xiewenlian cxcl13cxcr5axispredictspoorprognosisandpromotesprogressionthroughpi3kaktmtorpathwayinclearcellrenalcellcarcinoma |